Covered recipient · General Payments record
LAUREN TABOR
General Payments · PY2022–2024
$3,128.72
- Reported across 22 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $2,800.00 | 7 |
| Food and Beverage | $215.16 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| MIMEDX Group, Inc. | $2,800.00 | 7 |
| Novo Nordisk AS | $89.89 | 1 |
| Astellas Pharma US Inc | $47.25 | 3 |
| Medtronic, Inc. | $33.88 | 1 |
| Minerva Surgical, Inc | $16.14 | 1 |
| Biogen, Inc. | $14.92 | 1 |
| Meditrina | $13.08 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $15.99 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140286477 | CMS |
| Astellas Pharma US Inc | $15.13 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140286963 | CMS |
| Astellas Pharma US Inc | $16.13 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140287299 | CMS |
| Biogen, Inc. | $14.92 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104859284 | CMS |
| Meditrina | $13.08 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154267680 | CMS |
| Medtronic, Inc. | $33.88 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116874025 | CMS |
| MIMEDX Group, Inc. | $200.00 | 04/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1140270434 | CMS |
| MIMEDX Group, Inc. | $400.00 | 05/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1140270436 | CMS |
| MIMEDX Group, Inc. | $1,200.00 | 06/03/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1140270438 | CMS |
| MIMEDX Group, Inc. | $200.00 | 07/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1140270440 | CMS |
| MIMEDX Group, Inc. | $400.00 | 08/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1140270442 | CMS |
| MIMEDX Group, Inc. | $200.00 | 09/03/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1140270444 | CMS |
| MIMEDX Group, Inc. | $200.00 | 12/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1140270446 | CMS |
| Minerva Surgical, Inc | $16.14 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1085611193 | CMS |
| Novo Nordisk Inc | $89.89 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108579820 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.